BRAF and melanoma: Second and to our opinion most relevant, we show that SEMA6A is involved in the mechanisms that regulate the sensitivity of BRAF-mut melanoma cells to dual BRAF/MEK inhibition therapy and acts as a crucial mediator of melanoma-stroma communication.